Sejin Lee, PhD

Sejin Lee, PhD is a Postdoctoral Fellow in the Department of Medical Ethics and Health Policy at the Perelman School of Medicine. Her research focuses on pharmaceuticals policy, cancer outcomes, and patient reported outcomes research. Prior to her PhD program, she worked primarily in the global biopharmaceutical industry in a number of roles across clinical research, regulatory affairs, and healthcare analytics services. At Penn, she is working with Professor Holly Fernandez Lynch and collaborators on a project examining barriers, facilitators, and alternatives to confirming benefit after FDA grants early drug approval. She received her PhD from the University of North Carolina at Chapel Hill in the Department of Health Policy and Management in 2022. Her dissertation examined treatment decision making and patterns of treatment in older adults with advanced melanoma, focusing on immunotherapy and targeted therapy.